Enabling Anyone to Translate Clinically Relevant Ideas to Therapies.

作者: Sean Ekins , Natalie Diaz , Julia Chung , Paul Mathews , Aaron McMurtray

DOI: 10.1007/S11095-016-2039-5

关键词:

摘要: How do we inspire new ideas that could lead to potential treatments for rare or neglected diseases, and allow serendipity help catalyze them? many potentially good are lost because they never tested? What if those have therapeutic approaches major healthcare advances? If a clinician anyone matter, has idea want test develop molecule translate the clinic, how would it without laboratory funding? These not idle theoretical questions but addressing them huge economic implications nations. fail capture diversity of may also lose out on next blockbuster treatments. Many involved in process ideation be discouraged simply know where go. We try address these describe there options raising funding, even small scale investments can foster preclinical clinical translation, several outsourcing experiments, whether collaborators commercial enterprises. While far from complete solutions, first steps taken by virtually while work other solutions build more concrete structure “idea—hypothesis testing—proof concept—translation—breakthrough pathway”.

参考文章(34)
Sean Ekins, Moses M. Hohman, Barry A. Bunin, Pioneering Use of the Cloud for Development of Collaborative Drug Discovery (CDD) Database John Wiley & Sons, Inc.. pp. 335- 361 ,(2011) , 10.1002/9781118026038.CH21
Alan Macfarlane, Japan Through the Looking Glass ,(2007)
Walter Sneader, Drug Discovery: A History ,(2005)
Sean Ekins, Lori Sames, Allison Moore, Renée J.G. Arnold, Recommendations to enable drug development for inherited neuropathies: Charcot-Marie-Tooth and Giant Axonal Neuropathy. F1000Research. ,vol. 3, pp. 83- 83 ,(2014) , 10.12688/F1000RESEARCH.3751.2
Jill Wood, Lori Sames, Allison Moore, Sean Ekins, Multifaceted roles of ultra-rare and rare disease patients/parents in drug discovery. Drug Discovery Today. ,vol. 18, pp. 1043- 1051 ,(2013) , 10.1016/J.DRUDIS.2013.08.006
Ethan O Perlstein, Anatomy of the Crowd4Discovery crowdfunding campaign. SpringerPlus. ,vol. 2, pp. 560- 560 ,(2013) , 10.1186/2193-1801-2-560
Sean Ekins, Chris L. Waller, Mary P. Bradley, Alex M. Clark, Antony J. Williams, Four disruptive strategies for removing drug discovery bottlenecks. Drug Discovery Today. ,vol. 18, pp. 265- 271 ,(2013) , 10.1016/J.DRUDIS.2012.10.007
Anne R. Pariser, William A. Gahl, Important Role of Translational Science in Rare Disease Innovation, Discovery, and Drug Development Journal of General Internal Medicine. ,vol. 29, pp. 804- 807 ,(2014) , 10.1007/S11606-014-2881-2
Jayme L. Dahlin, James Inglese, Michael A. Walters, Mitigating risk in academic preclinical drug discovery Nature Reviews Drug Discovery. ,vol. 14, pp. 279- 294 ,(2015) , 10.1038/NRD4578
Nayanah Siva, Crowdfunding for medical research picks up pace. The Lancet. ,vol. 384, pp. 1085- 1086 ,(2014) , 10.1016/S0140-6736(14)61661-5